NCT06654050 2026-03-17
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
Clinical Trials
12 trialsNCT04214015 2025-06-05
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
ProgenaBiome
Withdrawn
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT06090318 2023-10-19
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Rain Oncology Inc
Phase 1/2 Withdrawn
NCT04429204 2021-06-14
Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma
Jonsson Comprehensive Cancer Center
Phase NA Withdrawn
NCT02661659 2018-05-14
A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
University of Chicago
Phase 1 Withdrawn
NCT02567396 2017-04-24
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT02661100 2016-12-07
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
Case Comprehensive Cancer Center
Phase 1/2 Withdrawn
NCT02511600 2015-12-15
Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication
M.D. Anderson Cancer Center
Phase 3 Withdrawn
NCT00785239 2015-06-25
CryoSpray Ablation(tm)Thoracic Patient Registry
CSA Medical, Inc.
Withdrawn
NCT00668499 2014-05-21
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma
University of Southern California
Phase 1/2 Withdrawn
NCT01353482 2012-03-22
MESO-02
University College, London
Phase 1/2 Withdrawn